A
Affinium Pharmaceuticals
Interactive web development agency specializing in web strategy, UX design, analytics, and search marketing for global companies
About Affinium Pharmaceuticals
PINT Inc., headquartered in San Diego since 1994, is a nationally recognized interactive web development agency. The company offers a comprehensive suite of services including web strategy, UX design, user experience, analytics, search marketing, and optimization. PINT serves a diverse range of global companies and institutions, helping them enhance their online presence and achieve their digital goals. The business operates on a service-based model, generating revenue through project-based engagements and ongoing service contracts. PINT's founder, Thomas Powell, is a notable figure in the industry, having authored eleven best-selling textbooks on HTML and web design. For more updates and information, visit the PINT blog or follow them on Twitter.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Feb 2014 | $0 | — | Debiopharm Group | — |
| DEBTDebt | Sep 2013 | $12M | — | Forward Ventures · Oxford Bioscience Partners · SV Health Investors | — |
Growth signals
Latest recorded traffic for Affinium Pharmaceuticals is 0 monthly website visits, down 100% over the last three months. Affinium Pharmaceuticals's team declined 2.2% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Affinium Pharmaceuticals in the Austin ecosystem
The Affinium Pharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
- FVForward Ventures
- OPOxford Bioscience Partners
Genesys Capital
SV Health Investors
Genesis Capital
Other known investors1 additional known investor
Debiopharm Group
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Affinium Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Affinium Pharmaceuticals’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.





